// App-Quantinova.ai

P136 : T-cell-Specific Biomarkers of Early Treatment Response in Patients with Rheumatoid Arthritis Treated with a Tumour Necrosis Factor Inhibitor

Researchers

Presenter

  • Megan A Sutcliffe

Principal Investigators

  • Stephanie Ling

  • Antonia Banyard

  • Laurie Rumker

  • Sebastien Viatte

  • Andrew Morris

  • Anne Barton

  • Soumya Raychaudhuri

  • Darren Plant

Medical Centers

  • Cancer Research UK Manchester Institute, University of Manchester, Manchester, United Kingdom.

  • Division of Musculoskeletal and Dermatological Sciences, University of Manchester, Manchester, United Kingdom

  • Center for Data Sciences, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Adalimumab

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved